about
Recombinant human parathyroid hormone related protein 1-34 and 1-84 and their roles in osteoporosis treatment.The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.Causes, consequences, and treatment of osteoporosis in men.The use of PTH in the treatment of osteoporosis.The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation.Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anabolic skeletal therapy for osteoporosis.
@ast
Anabolic skeletal therapy for osteoporosis.
@en
type
label
Anabolic skeletal therapy for osteoporosis.
@ast
Anabolic skeletal therapy for osteoporosis.
@en
prefLabel
Anabolic skeletal therapy for osteoporosis.
@ast
Anabolic skeletal therapy for osteoporosis.
@en
P2860
P1476
Anabolic skeletal therapy for osteoporosis.
@en
P2093
Mishaela R Rubin
Monica Girotra
P2860
P304
P356
10.1590/S0004-27302006000400019
P577
2006-08-01T00:00:00Z